Elaine Smith-Marchant, MD
Procedural Dermatology · Dania, FLNPI 1598712804
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Sanofi at 35.9% of the total. That places this record below the midpoint for procedural dermatology clinicians in FL, where the typical reported total is $1,299.
Across 33 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$291
- AbbVie$218
- Botanix SB Inc$79
- Novartis$73
- Incyte Corporation$50
- Sun Pharmaceutical Industries Inc.$36
- plus $64 from 3 others
What the payments were for
- Food & beverage$811100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 9 | $291 |
| AbbVie | 12 | $218 |
| Botanix SB Inc | 3 | $79 |
| Novartis | 3 | $73 |
| Incyte Corporation | 2 | $50 |
| Sun Pharmaceutical Industries Inc. | 1 | $36 |
| Mayne Pharma Commercial LLC | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $18 |
How this compares
$811 in reported general payments places this provider in the 40th percentile of 60 procedural dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 88 | $3,190 |
| Tacrolimus | 16 | $2,625 |
| Ketoconazole | 96 | $1,227 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 17 | $1,189 |
| Triamcinolone Acetonide | 82 | $1,054 |
| Ammonium Lactate | 36 | $962 |
| Clindamycin Phosphate | 15 | $810 |
| Doxycycline Hyclate | 34 | $497 |
| Hydrocortisone | 38 | $446 |
| Mupirocin | 47 | $392 |
| Hydroxyzine Hcl | 33 | $282 |
| Minoxidil | 22 | $186 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Dania
- Luis SoroFort Lauderdale$307K
- Laertes ManuelidisFort Myers$252K
- Michael ScannonTampa$218K
- Christopher OconnellCoral Gables$76K
- Dimitry PalceskiWinter Park$23K
- Samantha MarroneOrlando$22K
- Robert BrownOrange Park$22K
- Ileana Perez-QuintairosSouth Miami$16K
- Lawrence StrongWellington$13K
- Melanie HaynesPinellas Park$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.